FDA Inspection
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. – FDA Inspection, Jan 17, 2017
Record Details
This FDA Inspection record concerns Octapharma Pharmazeutika Produktionsgesellschaft m.b.H., with an inspection on January 17, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 17, 2017
- Product Type
- Biologics
View Company Profile
ID · dbc69e2f-7dc6-4686-823b-67e414e440a4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002598
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 16, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 16, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 5, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 18, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
- FDA Inspection 1194258 - 2022-12-16
- FDA Inspection 1090370 - 2019-04-16
- FDA Inspection 918160 - 2015-03-05
- FDA Inspection 816229 - 2012-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.